Zynex (ZYXI) Days Sales Outstanding

: 58.02 (As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

Zynex's average Accounts Receivable for the three months ended in Dec. 2023 was $30.1 Mil. Zynex's Revenue for the three months ended in Dec. 2023 was $47.3 Mil. Hence, Zynex's Days Sales Outstanding for the three months ended in Dec. 2023 was 58.02.

The historical rank and industry rank for Zynex's Days Sales Outstanding or its related term are showing as below:

ZYXI' s Days Sales Outstanding Range Over the Past 10 Years
Min: 28.45 Med: 60.39 Max: 167.81
Current: 63.45

During the past 13 years, Zynex's highest Days Sales Outstanding was 167.81. The lowest was 28.45. And the median was 60.39.

ZYXI's Days Sales Outstanding is ranked better than
60.42% of 96 companies
in the Medical Distribution industry
Industry Median: 77.31 vs ZYXI: 63.45

Zynex's Days Sales Outstanding declined from Dec. 2022 (59.28) to Dec. 2023 (58.02).

Zynex Days Sales Outstanding Historical Data

The historical data trend for Zynex's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zynex Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

34.61

44.80

59.48

73.49

61.29

Zynex Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Days Sales Outstanding	Get a 7-Day Free Trial															59.28	72.62	65.99	60.55	58.02

Competitive Comparison

For the Medical Distribution subindustry, Zynex's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Zynex Days Sales Outstanding Distribution

For the Medical Distribution industry and Healthcare sector, Zynex's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Zynex's Days Sales Outstanding falls into.

Zynex Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Zynex's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (35.063	+	26.838)	/	2 )	/	184.322	*	365
=	30.9505					/	184.322	*	365
=	61.29

Zynex's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Sep. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (33.288	+	26.838)	/	2 )	/	47.285	*	365 / 4
=	30.063					/	47.285	*	365 / 4
=	58.02

Zynex (NAS:ZYXI) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Zynex Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Zynex's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Zynex (ZYXI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Zynex Inc (NAS:ZYXI) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

9555 Maroon Circle, Englewood, CO, USA, 80112

Website

https://www.zynex.com

Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufacture, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. it also develops and markets medical devices for non-invasive cardiac monitoring, the products of which are under development. The company markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave and others.

Executives

Daniel J Moorhead	officer: Chief Financial Officer	9777 PYRAMID CT, STE 100, ENGLEWOOD CO 80112
Anna Lucsok	officer: See Remarks	9555 MAROON CIRCLE, ENGLEWOOD CO 80112
Thomas Sandgaard	director, 10 percent owner, officer: President, CEO and Chairman	10506 KALAHARI CT., LONE TREE CO 80124
Neil Friery	officer: See Remarks	C/O ZYNEX, INC. 9555 MAROON CIRCLE, ENGLEWOOD CO 80112
Joshua R. Disbrow	director	AMPIO PHARMACEUTICALS, INC., 5445 DTC PARKWAY, SUITE 925, GREENWOOD VILLAGE CO 80111
Barry D Michaels	director	6275 NANCY RIDGE DRIVE, SUITE 110, SAN DIEGO CA 92121
Michael D Cress	director	3409 ESPERANZA CROSSING SUITE 7110, AUSTIN TX 78758
Sandgaard Holdings Llc	10 percent owner	9555 MAROON CIRCLE, ENGLEWOOD CO 80112
Giuseppe Papandrea	officer: Chief Operating Officer	C/O ZYNEX, INC. 9555 MAROON CIRCLE, ENGLEWOOD CO 80112